Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective ...

Regulatory scrutiny on traditional excipients like titanium dioxide and talc poses significant challenges, necessitating robust scientific evidence to address concerns. Sustainable practices in ...

State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules.

Picking a date for a press conference in Puerto Rico in the middle of hurricane season can be risky business. | Eli Lilly has ...

American Petroleum Institute CEO Mike Sommers joins 'Varney & Co.' to discuss how rising energy costs in New Jersey and Virginia are influencing the states’ gubernatorial races and fueling voter ...

VAI means objectionable conditions or practices were found, but the regulator is not prepared to take or recommend any administrative or regulatory action.

Next year will be the twentieth anniversary of a successful lawsuit against the state, “Myers v. Alaska Psychiatric Institute ...

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

India on Monday advanced an anti-dumping investigation into imports from China and Thailand of Ethambutol Hydrochloride, an ...

The US drug regulator has turned its lens on Hetero, issuing back-to-back Form 483s to its API Unit 9 and warehouse in ...

Hyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an ...

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...